SARS-CoV-2: Immunopeptidomics and Other Immunological Studies

Vivek P Chavda1, Elrashdy M Redwan2,3

  • 1Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad 380008, India.

Vaccines
|November 24, 2022
PubMed
Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a global epidemic. This research investigates the ongoing impact and potential future directions for managing this significant public health threat.